IL22 and colitis: The decreased expression of proinflammatory cytokine and increased expression of anti-inflammatory cytokine were also observed in the miR-200b-3p- and miR-181b-5p-treated colitis groups, including IL-6, IL-1β and IL-10, but no significant changes in IL-22 was observed (Figure 3n and Figure S3K).